肠道微生物群-肠道代谢物和困难菌感染:寻找治疗的可持续解决方案
Bijay Gurung1,2,3, Maranda Stricklin1,2, Shaohua Wang1,2
1Department of Biomedical Sciences, Ohio University Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.
Metabolites
|January 26, 2024
概括
困难菌感染 (CDI) 是一个主要的医院威胁. 恢复肠道微生物群和SCFA等代谢物可能会提供超越抗生素的新型CDI预防策略.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 艰难菌感染 (CDI) 是一种普遍的医院获得的感染,复发率高,抗生素耐药性高.
- 目前的治疗方法,如抗生素和便微生物群移植,都有局限性和风险.
- 肠道微生物群失调是CDI的主要风险因素,使其成为关键的治疗点.
研究的目的:
- 审查肠道微生物群及其代谢物在CDI病变发生中的作用.
- 探索与CDI相关的特定微生物和代谢特征.
- 讨论调节肠道微生物群的因素及其作为治疗策略的潜力.
主要方法:
- 文献综述侧重于肠道微生物群,肠道代谢物 (二次胆汁酸,SCFA) 和CDI.
- 对将肠道失调和代谢物减少与CDI发展联系起来的机制的分析.
- 检查影响肠道微生物群组成和功能的因素.
主要成果:
- 肠道微生物群失调和二次胆酸和SCFA水平降低是CDI的特征.
- 肠道微生物群调节剂,包括益生菌和益生菌,可以恢复微生物平衡和代谢物生产.
- 特定的微生物和代谢特征与CDI的发病有关.
结论:
- 了解肠道微生物群和代谢物之间的相互作用对于开发新型CDI疗法至关重要.
- 益生菌和益生菌显示承诺通过恢复肠道健康预防策略.
- 向肠道微生物群和代谢物为CDI管理提供了抗生素和便移植的可持续替代方案.
相关概念视频
Bacterial Flora of the Large Intestine
451
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
451
Drugs for Treatment of Constipation-Predominant IBS
169
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
169
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
120
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
120
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
What is Monogastric Digestion?
71.2K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.2K


